New Key Statistics Module, Z-Score and F-Score
NAS:RADX Key Ratios
| Market Cap $ M | 9,022.67 |
| Enterprise Value $ M | 9,010.58 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | 0.38 |
| Price/Sales | 23.00 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | -- |
| EPS (TTM) $ | -- |
| Beneish M-Score | -4.31 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | -- |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | -0.66 |
| EV-to-EBITDA | -0.71 |
| PEG | -- |
| Shares Outstanding M | 2,200.65 |
| Net Margin (%) | -16,036.45 |
| Operating Margin % | -12,247.83 |
| Pre-tax Margin (%) | -16,004.35 |
| Quick Ratio | 1.30 |
| Current Ratio | 1.30 |
| ROA % (ttm) | -68.41 |
| ROE % (ttm) | -148.69 |
| ROIC % (ttm) | -60.05 |
| Dividend Yield % | -- |
| Altman Z-Score | -3.55 |
RADX Number of Guru Trades
RADX Volume of Guru Trades
Gurus Latest Trades with NAS:RADX
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:RADX is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Radiopharm Theranostics Ltd Insider Transactions
No Available Data
News about NAS:RADX
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers